<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36827976</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-6711</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>Stem cell reports</Title><ISOAbbreviation>Stem Cell Reports</ISOAbbreviation></Journal><ArticleTitle>Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology.</ArticleTitle><Pagination><StartPage>706</StartPage><EndPage>719</EndPage><MedlinePgn>706-719</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stemcr.2023.01.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-6711(23)00015-2</ELocationID><Abstract><AbstractText>Loss of function (LoF) of TAR-DNA binding protein 43 (TDP-43) and mis-localization, together with TDP-43-positive and hyperphosphorylated inclusions, are found in post-mortem tissue of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, including those carrying LoF variants in the progranulin gene (GRN). Modeling TDP-43 pathology has been challenging in&#xa0;vivo and in&#xa0;vitro. We present a three-dimensional induced pluripotent stem cell (iPSC)-derived paradigm-mature brain organoids (mbOrg)-composed of cortical-like-astrocytes (iA) and neurons. When devoid of GRN, mbOrgs spontaneously recapitulate TDP-43 mis-localization, hyperphosphorylation, and LoF phenotypes. Mixing and matching genotypes in mbOrgs showed that GRN<sup>-/-</sup> iA are drivers for TDP-43 pathology. Finally, we rescued TDP-43 LoF by adding exogenous progranulin, demonstrating a link between TDP-43 LoF and progranulin expression. In conclusion, we present an iPSC-derived platform that shows striking features of human TDP-43 proteinopathy and provides a tool for the mechanistic modeling of TDP-43 pathology and patient-tailored therapeutic screening for FTD and ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Majo</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA; Synapticure Inc, Chicago, IL 60612, USA. Electronic address: martina@synapticure.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koontz</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA; Synapticure Inc, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsan</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas</LastName><ForeName>Nir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramsey</LastName><ForeName>Arren</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Yien-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Kyounghee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huinan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dr&#xe4;ger</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leng</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales</LastName><ForeName>Santiago L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurnellas</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alector, Inc, South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyaoka</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Regenerative Medicine Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan; Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klim</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampmann</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA; Neuroscience Graduate Program, University of California San Francisco, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullian</LastName><ForeName>Erik M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA; Neuroscience Graduate Program, University of California San Francisco, San Francisco, CA 94158, USA. Electronic address: erik.ullian@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 EY002162</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062359</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cell Reports</MedlineTA><NlmUniqueID>101611300</NlmUniqueID><ISSNLinking>2213-6711</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077155">Granulins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077153">Progranulins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077155" MajorTopicYN="N">Granulins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077153" MajorTopicYN="N">Progranulins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">iPSC</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neurons</Keyword><Keyword MajorTopicYN="N">strocyte-neuronal signaling</Keyword></KeywordList><CoiStatement>Conflict of interests M.dM. and M.Koontz are full-time employees and equity holders of Synapticure Inc. E.M.U. is an equity holder of Synapticure Inc. M. Kampmann is an inventor on U.S. Patent 11,254,933 related to CRISPRi and CRISPRa screening, serves on the Scientific Advisory Boards of Engine Biosciences, Casma Therapeutics, Cajal Neuroscience, and Alector, and is an advisor to Modulo Bio and Recursion Therapeutics. J.R.K. is a shareholder of Faze Medicines and QurAlis, and is an author on patent that describes surfaces for the long-term culture of pluripotent cells (U.S. patent 8,648,170) as well as a patent application that describes methods and compositions for restoring STMN2 levels (U.S. patent application 20,220,133,848). M.Kurnellas is a full-time employee and has equity interest in Alector, Inc. N.M.Dr&#xe4;ger is a full time employee at Modulo Bio, Inc. All other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>18</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36827976</ArticleId><ArticleId IdType="pmc">PMC10031303</ArticleId><ArticleId IdType="doi">10.1016/j.stemcr.2023.01.012</ArticleId><ArticleId IdType="pii">S2213-6711(23)00015-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed Z., Sheng H., Xu Y., Lin W.-L., Innes A.E., Gass J., Yu X., Hou H., Chiba S., Yamanouchi K., et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am. J. Pathol. 2010;177:311&#x2013;324. doi: 10.2353/ajpath.2010.090915.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090915</ArticleId><ArticleId IdType="pmc">PMC2893674</ArticleId><ArticleId IdType="pubmed">20522652</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama T., Koike Y., Petrucelli L., Gitler A.D. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: towards therapeutic targets and biomarkers. Clin. Transl. Med. 2022;12 doi: 10.1002/ctm2.818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.818</ArticleId><ArticleId IdType="pmc">PMC9098226</ArticleId><ArticleId IdType="pubmed">35567447</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S., Zhang Z., Coppola G., Mao W., Futai K., Karydas A., Geschwind M.D., Tartaglia M.C., Gao F., Gianni D., et al. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep. 2012;2:789&#x2013;798. doi: 10.1016/j.celrep.2012.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.09.007</ArticleId><ArticleId IdType="pmc">PMC3532907</ArticleId><ArticleId IdType="pubmed">23063362</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006 doi: 10.1038/nature05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05016</ArticleId><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C., Grenier-Boley B., Lambert J.-C. Genetics of Alzheimer&#x2019;s disease: where we are, and where we are going. Curr. Opin. Neurobiol. 2020;61:40&#x2013;48. doi: 10.1016/j.conb.2019.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2019.11.024</ArticleId><ArticleId IdType="pubmed">31863938</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchard J.W., Bula M., Davila-Velderrain J., Akay L.A., Zhu L., Frank A., Victor M.B., Bonner J.M., Mathys H., Lin Y.-T., et al. Author Correction: reconstruction of the human blood&#x2013;brain barrier in&#xa0;vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat. Med. 2021;27:356. doi: 10.1038/s41591-021-01250-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01250-8</ArticleId><ArticleId IdType="pubmed">33514950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossolasco P., Cimini S., Maderna E., Bardelli D., Canafoglia L., Cavallaro T., Ricci M., Silani V., Marucci G., Rossi G. GRN&#x2212;/&#x2212; iPSC-derived cortical neurons recapitulate the pathological findings of both frontotemporal lobar degeneration and neuronal ceroidolipofuscinosis. Neurobiol. Dis. 2022:105891. doi: 10.1016/j.nbd.2022.105891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105891</ArticleId><ArticleId IdType="pubmed">36220610</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A.-L., Wilkins O.G., Keuss M.J., Hill S.E., Zanovello M., Lee W.C., Bampton A., Lee F.C.Y., Masino L., Qi Y.A., et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;13:16. doi: 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. Targeting TDP-43 proteinopathy with drugs and drug-like small molecules. Br. J. Pharmacol. 2020 doi: 10.1111/bph.15148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15148</ArticleId><ArticleId IdType="pubmed">32469420</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Halliday G.M., Kril J.J., Ittner L.M., G&#xf6;tz J., Kiernan M.C., Hodges J.R. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016 doi: 10.1016/S0140-6736(15)60684-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60684-5</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., White L.A. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung W.-S., Clarke L.E., Wang G.X., Stafford B.K., Sher A., Chakraborty C., Joung J., Foo L.C., Thompson A., Chen C., et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504:394&#x2013;400. doi: 10.1038/nature12776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12776</ArticleId><ArticleId IdType="pmc">PMC3969024</ArticleId><ArticleId IdType="pubmed">24270812</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Baskerville V., Zaepfel B.L., Dickson D.W., Rigo F., Bennett F., Patrick Lusk C., Rothstein J.D. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 2021;13 doi: 10.1126/scitranslmed.abe1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe1923</ArticleId><ArticleId IdType="pmc">PMC9022198</ArticleId><ArticleId IdType="pubmed">34321318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006 doi: 10.1038/nature05017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05017</ArticleId><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai M.K., Mastrangelo M.A., Ryan D.A., Sudol K.L., Narrow W.C., Bowers W.J. Early oligodendrocyte/myelin pathology in Alzheimer&#x2019;s disease mice constitutes a novel therapeutic target. Am. J. Pathol. 2010;177:1422&#x2013;1435. doi: 10.2353/ajpath.2010.100087.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.100087</ArticleId><ArticleId IdType="pmc">PMC2928974</ArticleId><ArticleId IdType="pubmed">20696774</ArticleId></ArticleIdList></Reference><Reference><Citation>Dr&#xe4;ger N.M., Sattler S.M., Huang C.T.-L., Teter O.M., Leng K., Hashemi S.H., Hong J., Aviles G., Clelland C.D., Zhan L., et al. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nat. Neurosci. 2022 doi: 10.1038/s41593-022-01131-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01131-4</ArticleId><ArticleId IdType="pmc">PMC9448678</ArticleId><ArticleId IdType="pubmed">35953545</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle M.S., Prestil R., Grunseich C., Wang C., Gan L., Michael E. Transcription-factor mediated differentiation of human iPSCs into neurons Running Title Rapid differentiation of iPSCs into neurons. Current Protocols in Cell Biology. 2018 doi: 10.1002/cpcb.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpcb.51</ArticleId><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Z., Chen Z., Fu S., Dai L., Shen Y. Progranulin administration attenuates &#x3b2;-amyloid deposition in the Hippocampus of 5xFAD mice through modulating BACE1 expression and microglial phagocytosis. Front. Cell. Neurosci. 2020;14 doi: 10.3389/fncel.2020.00260.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00260</ArticleId><ArticleId IdType="pmc">PMC7461932</ArticleId><ArticleId IdType="pubmed">32973454</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen D.v., Hanson J.E., Sheng M. JCB (J. Cell Biol.) Vol. 217. Rockefeller University Press; 2018. Microglia in Alzheimer&#x2019;s disease; pp. 459&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709069</ArticleId><ArticleId IdType="pmc">PMC5800817</ArticleId><ArticleId IdType="pubmed">29196460</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Li C., Shang H. Astrocytes in neurodegeneration: inspiration from genetics. Front. Neurosci. 2022;16 doi: 10.3389/fnins.2022.882316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.882316</ArticleId><ArticleId IdType="pmc">PMC9268899</ArticleId><ArticleId IdType="pubmed">35812232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley K.W., Nakao-Inoue H., Molofsky A.v., Oldham M.C. Variation among intact tissue samples reveals the core transcriptional features of human CNS cell classes. Nat. Neurosci. 2018;21:1171&#x2013;1184. doi: 10.1038/s41593-018-0216-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0216-z</ArticleId><ArticleId IdType="pmc">PMC6192711</ArticleId><ArticleId IdType="pubmed">30154505</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim J.R., Williams L.A., Limone F., San Juan I.G., Davis-Dusenbery B.N., Mordes D.A., Butberry A., Steinbaugh M.J., Gamage K.K., Kirchner R., et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. 2019;22 doi: 10.1038/s41593-018-0300-4.ALS.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4.ALS</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D.S., Roberts R.O. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J.&#xa0;Mol. Neurosci. 2011;45:330&#x2013;335. doi: 10.1007/s12031-011-9538-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9538-y</ArticleId><ArticleId IdType="pmc">PMC3208074</ArticleId><ArticleId IdType="pubmed">21584654</ArticleId></ArticleIdList></Reference><Reference><Citation>Krencik R., Hokanson K.C., Narayan A.R., Dvornik J., Rooney G.E., Rauen K.A., Weiss L.A., Rowitch D.H., Ullian E.M. Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci. Transl. Med. 2015;7:1&#x2013;12. doi: 10.1126/scitranslmed.aaa5645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa5645</ArticleId><ArticleId IdType="pmc">PMC4474402</ArticleId><ArticleId IdType="pubmed">25947161</ArticleId></ArticleIdList></Reference><Reference><Citation>Krencik R., Seo K., van Asperen J.v., Basu N., Cvetkovic C., Barlas S., Chen R., Ludwig C., Wang C., Ward M.E., et al. Systematic three-dimensional coculture rapidly recapitulates interactions between human neurons and astrocytes. Stem Cell Rep. 2017;9:1745&#x2013;1753. doi: 10.1016/j.stemcr.2017.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.10.026</ArticleId><ArticleId IdType="pmc">PMC5785708</ArticleId><ArticleId IdType="pubmed">29198827</ArticleId></ArticleIdList></Reference><Reference><Citation>Krencik R., Zhang S.-C. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat. Protoc. 2011;6:1710&#x2013;1717. doi: 10.1038/nprot.2011.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.405</ArticleId><ArticleId IdType="pmc">PMC3198813</ArticleId><ArticleId IdType="pubmed">22011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., D&#x2019;Souza S.S., Moskvin O.V., Toh H., Wang B., Zhang J., Swanson S., Guo L.-W., Thomson J.A., Slukvin I.I. Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts. Cell Rep. 2017;19:1902&#x2013;1916. doi: 10.1016/j.celrep.2017.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.019</ArticleId><ArticleId IdType="pmc">PMC6428685</ArticleId><ArticleId IdType="pubmed">28564607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Chung W.-S. Glial control of synapse number in healthy and diseased brain. Front. Cell. Neurosci. 2019;0:42. doi: 10.3389/FNCEL.2019.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNCEL.2019.00042</ArticleId><ArticleId IdType="pmc">PMC6381066</ArticleId><ArticleId IdType="pubmed">30814931</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, Huang E.J. Brain Res. Vol. 1656. Elsevier B.V; 2017. Modeling ALS and FTD with iPSC-derived neurons; pp. 88&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.10.003</ArticleId><ArticleId IdType="pmc">PMC4833714</ArticleId><ArticleId IdType="pubmed">26462653</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K., Rose I.V.L., Kim H., Xia W., Romero-Fernandez W., Rooney B., Koontz M., Li E., Ao Y., Wang S., et al. CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states. Nat Neurosci. 2022;25:1528&#x2013;1542. doi: 10.1038/s41593-022-01180-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01180-9</ArticleId><ArticleId IdType="pmc">PMC9633461</ArticleId><ArticleId IdType="pubmed">36303069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017 doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033. Converging.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.J., Malatesta M., Lien B.V., Saha P., Thombare S.S., Hong S.J., Pedraza L., Koontz M., Seo K., Horlbeck M.A., et al. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma. Genome Biol. 2020;21:83. doi: 10.1186/s13059-020-01995-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-020-01995-4</ArticleId><ArticleId IdType="pmc">PMC7110660</ArticleId><ArticleId IdType="pubmed">32234056</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan T., Simon M.J., Rana A., Cherf G.M., Srivastava A., Davis S.S., Low R.L.Y., Chiu C.L., Fang M., Huang F., et al. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. Cell. 2021;184:4651&#x2013;4668.e25. doi: 10.1016/j.cell.2021.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.08.002</ArticleId><ArticleId IdType="pmc">PMC8489356</ArticleId><ArticleId IdType="pubmed">34450028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui H., Zhang J., Makinson S.R., Cahill M.K., Kelley K.W., Huang H.Y., Shang Y., Oldham M.C., Martens L.H., Gao F., et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell. 2016;165:921&#x2013;935. doi: 10.1016/j.cell.2016.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.001</ArticleId><ArticleId IdType="pmc">PMC4860138</ArticleId><ArticleId IdType="pubmed">27114033</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A. Acta Neuropathologica. 2007. The neuropathology and clinical phenotype of FTD with progranulin mutations.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0223-8</ArticleId><ArticleId IdType="pubmed">17458552</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle J.L., Lee K.H. A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-&#x3b1; and IL-6 in an iPSC-based blood-brain barrier model. Neurobiol. Dis. 2018;119:113&#x2013;120. doi: 10.1016/j.nbd.2018.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.030</ArticleId><ArticleId IdType="pubmed">30075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z., L&#xf3;pez-Erauskin J., Baughn M.W., Zhang O., Drenner K., Sun Y., Freyermuth F., McMahon M.A., Beccari M.S., Artates J.W., et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180&#x2013;190. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyaoka Y., Chan A.H., Judge L.M., Yoo J., Huang M., Nguyen T.D., Lizarraga P.P., So P.-L., Conklin B.R. Isolation of single-base genome-edited human iPS cells without antibiotic selection. Nat. Methods. 2014;11:291&#x2013;293. doi: 10.1038/nmeth.2840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2840</ArticleId><ArticleId IdType="pmc">PMC4063274</ArticleId><ArticleId IdType="pubmed">24509632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Brayne C., Flanagan M.E., Abner E.L., Agrawal S., Attems J., Castellani R.J., Corrada M.M., Cykowski M.D., Di J., et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer&#x2019;s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022 doi: 10.1007/s00401-022-02444-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02444-1</ArticleId><ArticleId IdType="pmc">PMC9552938</ArticleId><ArticleId IdType="pubmed">35697880</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Dickson D.W., Trojanowski J.Q., Jack C.R., Boyle P.A., Arfanakis K., Rademakers R., Alafuzoff I., Attems J., Brayne C., et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503&#x2013;1527. doi: 10.1093/brain/awz099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz099</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, N.Y.) 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo V., Tosat-Bitrian C., Nozal V., Nagaraj S., Martin-Requero A., Martinez A. TDP-43: a key therapeutic target beyond amyotrophic lateral sclerosis. ACS Chem. Neurosci. 2019;10:1183&#x2013;1196. doi: 10.1021/acschemneuro.9b00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00026</ArticleId><ArticleId IdType="pubmed">30785719</ArticleId></ArticleIdList></Reference><Reference><Citation>Petoukhov E., Fernando S., Mills F., Shivji F., Hunter D., Krieger C., Silverman M.A., Bamji S.X. Activity-dependent secretion of progranulin from synapses. J.&#xa0;Cell Sci. 2013;126:5412&#x2013;5421. doi: 10.1242/jcs.132076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.132076</ArticleId><ArticleId IdType="pubmed">24046442</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Humphrey J., Pickles S., Brown A.-L., Hill S.E., Kachergus J., Shi J., Heckman M., Spiegel M., Cook C., et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J.&#xa0;Clin. Invest. 2020 doi: 10.1172/jci139741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci139741</ArticleId><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Quek H., Cun&#xed;-L&#xf3;pez C., Stewart R., Colletti T., Notaro A., Nguyen T.H., Sun Y., Guo C.C., Lupton M.K., Roberts T.L., et al. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. J.&#xa0;Neuroinflammation. 2022;19 doi: 10.1186/s12974-022-02421-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02421-1</ArticleId><ArticleId IdType="pmc">PMC8887023</ArticleId><ArticleId IdType="pubmed">35227277</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinn H., Tatton N., McCaughey S., Kurnellas M., Rosenthal A. Trends in Pharmacological Sciences. Elsevier Ltd; 2022. Progranulin as a therapeutic target in neurodegenerative diseases.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2021.11.015</ArticleId><ArticleId IdType="pubmed">35039149</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen E.Y., Wexler E.M., Versano R., Coppola G., Gao F., Winden K.D., Oldham M.C., Martens L.H., Zhou P., Farese R.V., Jr., Geschwind D.H. Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating wnt signaling. Neuron. 2011;71:1030&#x2013;1042. doi: 10.1016/j.neuron.2011.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.07.021</ArticleId><ArticleId IdType="pmc">PMC3633414</ArticleId><ArticleId IdType="pubmed">21943601</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H., Kamphorst W., Rosso S.M., Azmani A., Masdjedi R., de Koning I., Maat-Kievit J.A., Anar B., Kaat L.D., Breedveld G.J., et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008;71:1220. doi: 10.1212/01.wnl.0000319702.37497.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000319702.37497.72</ArticleId><ArticleId IdType="pubmed">18703462</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha D.M., Clarke B.E., Hall C.E., Tyzack G.E., Ziff O.J., Greensmith L., Kalmar B., Ahmed M., Alam A., Thelin E.P., et al. Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosis. Brain. 2022 doi: 10.1093/brain/awab328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab328</ArticleId><ArticleId IdType="pmc">PMC9014746</ArticleId><ArticleId IdType="pubmed">35042241</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia L., Milnerwood A., Guo A., Mills F., Yoshida E., Vasuta C., Mackenzie I.R., Raymond L., Cynader M., Jia W., Bamji S.X. Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses. J.&#xa0;Neurosci. 2011;31:11126. doi: 10.1523/JNEUROSCI.6244-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6244-10.2011</ArticleId><ArticleId IdType="pmc">PMC6623368</ArticleId><ArticleId IdType="pubmed">21813674</ArticleId></ArticleIdList></Reference><Reference><Citation>Uesaka N., Abe M., Konno K., Yamazaki M., Sakoori K., Watanabe T., Kao T.-H., Mikuni T., Watanabe M., Sakimura K., Kano M. Retrograde signaling from progranulin to Sort1 counteracts synapse elimination in the developing cerebellum. Neuron. 2018;97:796&#x2013;805.e5. doi: 10.1016/j.neuron.2018.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.01.018</ArticleId><ArticleId IdType="pubmed">29398357</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Olabarria M., Noristani H.N., Yeh C.-Y., Rodriguez J.J. Astrocytes in Alzheimer&#x2019;s disease. Neurotherapeutics. 2010;7:399&#x2013;412. doi: 10.1016/j.nurt.2010.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2010.05.017</ArticleId><ArticleId IdType="pmc">PMC5084302</ArticleId><ArticleId IdType="pubmed">20880504</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan J., M&#xe4;kinen P., Helisalmi S., Haapasalo A., Soininen H., Hiltunen M. An association study between granulin gene polymorphisms and Alzheimer&#x2019;s disease in Finnish population. Am. J. Med. Genet. Part B: Neuropsychiatric Genetics. 2009;150B5:747&#x2013;750. doi: 10.1002/ajmg.b.30889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30889</ArticleId><ArticleId IdType="pubmed">19016491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ward M.E., Chen R., Liu K., Tracy T.E., Chen X., Xie M., Sohn P.D., Ludwig C., Meyer-Franke A., et al. Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening. Stem Cell Rep. 2017;9:1221&#x2013;1233. doi: 10.1016/j.stemcr.2017.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.08.019</ArticleId><ArticleId IdType="pmc">PMC5639430</ArticleId><ArticleId IdType="pubmed">28966121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Chen J., Hu Y., Liao A., Zheng W., Wang X., Lan J., Shen J., Wang S., Yang F., et al. Progranulin improves neural development via the PI3K/Akt/GSK-3&#x3b2; pathway in the cerebellum of a VPA-induced rat model of ASD. Transl. Psychiatry. 2022;12:114. doi: 10.1038/s41398-022-01875-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-01875-4</ArticleId><ArticleId IdType="pmc">PMC8941112</ArticleId><ArticleId IdType="pubmed">35318322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward M.E., Taubes A., Chen R., Miller B.L., Sephton C.F., Gelfand J.M., Minami S., Boscardin J., Martens L.H., Seeley W.W., et al. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J.&#xa0;Exp. Med. 2014;211:1937&#x2013;1945. doi: 10.1084/jem.20140214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140214</ArticleId><ArticleId IdType="pmc">PMC4172214</ArticleId><ArticleId IdType="pubmed">25155018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Velmeshev D., Hashimoto K., Huang Y.H., Hofmann J.W., Shi X., Chen J., Leidal A.M., Dishart J.G., Cahill M.K., et al. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nature. 2020 doi: 10.1038/s41586-020-2709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2709-7</ArticleId><ArticleId IdType="pmc">PMC7746606</ArticleId><ArticleId IdType="pubmed">32866962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O'Keeffe S., Phatnani H.P., Guarnieri P., Caneda C., Ruderisch N., et al. An rna-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. The J. of Neuroscience. 2014;34:11929. doi: 10.1523/JNEUROSCI.1860-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1860-14.2014</ArticleId><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Sloan S.A., Clarke L.E., Caneda C., Plaza C.A., Blumenthal P.D., Vogel H., Steinberg G.K., Edwards M.S.B., Li G., et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37&#x2013;53. doi: 10.1016/j.neuron.2015.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.013</ArticleId><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>